{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T21:46:54Z","timestamp":1768772814407,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fujiwara Memorial Foundation"},{"name":"Mental Health Okamoto Memorial Foundation","award":["KEN37"],"award-info":[{"award-number":["KEN37"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Irritable bowel syndrome (IBS) is a common disease that affects the quality of life (QOL) and social functioning of sufferers. Visceral anxiety is currently considered a key factor in the onset and exacerbation of IBS, and cognitive-behavioural therapy (CBT) targeting visceral anxiety is thought to be effective. However, access to CBT is limited due to the lack of trained therapists, the substantial time required for therapy and the associated costs. Group CBT (GCBT) may solve some of these problems. We have therefore planned this trial to examine the efficacy of GCBT for IBS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The trial is a two-armed, parallel group, open label, stratified block randomized superiority trial. The study group will consist of 112 participants (aged 18\u201375\u2009years) with IBS (Rome-III or IV criteria). Participants will be randomly allocated 1:1 to (i) the intervention group: ten-week GCBT plus treatment as usual (TAU) or (ii) the control group: waiting list (WL) plus TAU. The co-primary outcomes are the change in IBS severity or disease-specific quality of life from baseline to week 13 which is 1\u2009month after the end of treatment. The efficacy of GCBT for IBS will be examined through mixed-effects repeated-measures analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>GCBT, if found effective, can address the issues of the shortage of therapists as well as the time required and the costs associated with individual CBT. Clinically, the findings will help make effective CBT programmes accessible to a large number of distressed IBS patients at lower costs. Theoretically, the results will clarify the relationship between IBS and psychological stress and will help elucidate the underlying mechanisms of IBS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>UMIN, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/upload.umin.ac.jp\/cgi-bin\/ctr_e\/ctr_view.cgi?recptno=R000035391\">CTR-UMIN000031710<\/jats:ext-link>. Registered on March 13, 2018.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-020-1157-z","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:06:45Z","timestamp":1612310805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6706-4912","authenticated-orcid":false,"given":"Shino","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Oe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirono","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Horikoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Seno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshi A.","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,4]]},"reference":[{"issue":"6","key":"1157_CR1","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","volume":"150","author":"BE Lacy","year":"2016","unstructured":"Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393\u20131407e5 Available from: https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031.","journal-title":"Gastroenterology"},{"issue":"7","key":"1157_CR2","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","volume":"10","author":"RM Lovell","year":"2012","unstructured":"Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712\u201321 Available from: https:\/\/doi.org\/10.1016\/j.cgh.2012.02.029.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1157_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1053\/gast.2000.16484","volume":"119","author":"IM Gralnek","year":"2000","unstructured":"Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119(3):654\u201360 Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508500477577.","journal-title":"Gastroenterology"},{"issue":"3","key":"1157_CR4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1572-0241.2003.07296.x","volume":"98","author":"G Longstreth","year":"2003","unstructured":"Longstreth G. Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol. 2003;98(3):600\u20137 Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002927002060185.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"1157_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1542-3565(04)00124-7","volume":"2","author":"CD Costanza","year":"2004","unstructured":"Costanza CD, Longstreth GF, Liu AL. Chronic abdominal wall pain: clinical features, health care costs, and long-term outcome. Clin Gastroenterol Hepatol. 2004;2(5):395\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"SUPPL. 1","key":"1157_CR6","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/ajg.2014.187","volume":"109","author":"AC Ford","year":"2014","unstructured":"Ford AC, Moayyedi P, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. American college of gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109(SUPPL. 1):S2\u201326 Available from: https:\/\/doi.org\/10.1038\/ajg.2014.187.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"1157_CR7","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/ajg.2014.148","volume":"109","author":"AC Ford","year":"2014","unstructured":"Ford AC, Quigley EMM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2014;109(9):1350\u201365 Available from: http:\/\/www.nature.com\/doifinder\/10.1038\/ajg.2014.148.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"1157_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.cgh.2015.11.020","volume":"14","author":"KT Laird","year":"2016","unstructured":"Laird KT, Tanner-Smith EE, Russell AC, Hollon SD, Walker LS. Short-term and long-term efficacy of psychological therapies for irritable bowel syndrome: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(7):937\u201347 Available from: https:\/\/doi.org\/10.1016\/j.cgh.2015.11.020.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"1157_CR9","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1136\/gut.2007.119446","volume":"56","author":"R Spiller","year":"2007","unstructured":"Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007;56(12):1770\u201398 Available from: http:\/\/gut.bmj.com\/cgi\/doi\/10.1136\/gut.2007.119446.","journal-title":"Gut"},{"key":"1157_CR10","unstructured":"National Institute for Health and Clinical Excellence. Irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care. London R Coll Nurs. 2008. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21656972. Accessed 6 Nov 2019."},{"issue":"6\u20137","key":"1157_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.brat.2011.04.001","volume":"49","author":"MG Craske","year":"2011","unstructured":"Craske MG, Wolitzky-Taylor KB, Labus J, Wu S, Frese M, Mayer EA, et al. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther. 2011;49(6\u20137):413\u201321 Available from: https:\/\/doi.org\/10.1016\/j.brat.2011.04.001.","journal-title":"Behav Res Ther"},{"issue":"1","key":"1157_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.2044-8260.1997.tb01233.x","volume":"36","author":"MG Craske","year":"1997","unstructured":"Craske MG, Rowe M, Lewin M, Noriega-Dimitri R. Interoceptive exposure versus breathing retraining within cognitive-behavioural therapy for panic disorder with agoraphobia. Br J Clin Psychol. 1997;36(1):85\u201399.","journal-title":"Br J Clin Psychol"},{"issue":"1","key":"1157_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4324\/9781315619996-3","volume":"108","author":"ME Bouton","year":"2018","unstructured":"Bouton ME, Mineka S, Barlow DH. A modern learning theory perspective on the etiology of panic disorder. Neurotic Parad Prog Underst Treat Anxiety Relat Disord. 2018;108(1):265\u2013324.","journal-title":"Neurotic Parad Prog Underst Treat Anxiety Relat Disord"},{"issue":"1","key":"1157_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brat.2004.12.005","volume":"44","author":"MM Antony","year":"2006","unstructured":"Antony MM, Ledley DR, Liss A, Swinson RP. Responses to symptom induction exercises in panic disorder. Behav Res Ther. 2006;44(1):85\u201398.","journal-title":"Behav Res Ther"},{"issue":"4","key":"1157_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0005-7967(86)90011-2","volume":"24","author":"D Clark","year":"1986","unstructured":"Clark D. A cognitive approach to panic. Behav Res Ther. 1986;24(4):461\u201370.","journal-title":"Behav Res Ther"},{"issue":"4","key":"1157_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/smi.941","volume":"18","author":"DH Barlow","year":"2002","unstructured":"Barlow DH. Anxiety and its disorders: the nature and treatment of anxiety and panic. Stress Health. 2002;18(4):193\u20134 Available from: http:\/\/doi.wiley.com\/10.1002\/smi.941.","journal-title":"Stress Health"},{"issue":"4","key":"1157_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/gut.41.4.505","volume":"41","author":"BD Naliboff","year":"1997","unstructured":"Naliboff BD, Munakata J, Fullerton S, Gracely RH, Kodner A, Harraf F, et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut. 1997;41(4):505\u201312.","journal-title":"Gut."},{"issue":"4","key":"1157_CR18","doi-asserted-by":"publisher","first-page":"A845","DOI":"10.1016\/S0016-5085(00)85521-3","volume":"118","author":"GN Verne","year":"2000","unstructured":"Verne GN, Price DD, Robinson ME. Hypersensitivity to cutaneous (heat induced) pain in the irritable bowel syndrome. Gastroenterology. 2000;118(4):A845.","journal-title":"Gastroenterology."},{"issue":"9","key":"1157_CR19","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/gutjnl-2011-300474","volume":"61","author":"NA Koloski","year":"2012","unstructured":"Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ. The brain\u2013gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut. 2012;61(9):1284\u201390 Available from: http:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2011-300474.","journal-title":"Gut"},{"issue":"3","key":"1157_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.cgh.2012.10.031","volume":"11","author":"OS Palsson","year":"2013","unstructured":"Palsson OS, Whitehead WE. Psychological treatments in functional gastrointestinal disorders: a primer for the gastroenterologist. Clin Gastroenterol Hepatol. 2013;11(3):208\u201316 Available from: https:\/\/doi.org\/10.1016\/j.cgh.2012.10.031.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"1157_CR21","first-page":"683","volume":"39","author":"T Vos","year":"2005","unstructured":"Vos T, Corry J, Haby MM, Carter R, Andrews G. Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depression. Aust N Z J Psychiatry. 2005;39(8):683\u201392.","journal-title":"Aust N Z J Psychiatry"},{"issue":"14","key":"1157_CR22","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1097\/BRS.0b013e318067dc26","volume":"32","author":"DJ Critchley","year":"2007","unstructured":"Critchley DJ, Ratcliffe J, Noonan S, Jones RH, Hurley MV. Effectiveness and cost-effectiveness of three types of physiotherapy used to reduce chronic low back pain disability: a pragmatic randomized trial with economic evaluation. Spine (Phila Pa 1976). 2007;32(14):1474\u201381.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"3","key":"1157_CR23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K. Research and reporting methods annals of internal medicine SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137 Available from: http:\/\/annals.org\/article.aspx?doi=10.7326\/0003-4819-158-3-201302050-00583.","journal-title":"Ann Intern Med"},{"issue":"March","key":"1157_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.g1687","volume":"348","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348(March):1\u201312 Available from: https:\/\/doi.org\/10.1136\/bmj.g1687.","journal-title":"BMJ"},{"issue":"6","key":"1157_CR25","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","volume":"150","author":"WL Hasler","year":"2016","unstructured":"Hasler WL. Rome IV - functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257\u201361 Available from: https:\/\/doi.org\/10.1053\/j.gastro.2016.03.035.","journal-title":"Gastroenterology"},{"issue":"1","key":"1157_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00535-014-1017-0","volume":"50","author":"S Fukudo","year":"2014","unstructured":"Fukudo S, Kaneko H, Akiho H, Inamori M, Endo Y, Okumura T, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol. 2014;50(1):11\u201330 Available from: https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-84925515920&partnerID=40&md5=ef4d9d7bbe23c6b606949064849cff45.","journal-title":"J Gastroenterol"},{"issue":"1","key":"1157_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1471-230X-11-110","volume":"11","author":"B Lj\u00f3tsson","year":"2011","unstructured":"Lj\u00f3tsson B, Andersson G, Andersson E, Hedman E, Lindfors P, Andr\u00e9ewitch S, et al. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol. 2011;11(1):110 Available from: http:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-11-110.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"1157_CR28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cgh.2017.12.026","volume":"16","author":"CV Almario","year":"2018","unstructured":"Almario CV, Spiegel BMR. Employing irritable bowel syndrome patient-reported outcomes in the clinical trenches. Clin Gastroenterol Hepatol. 2018;16(4):462\u2013466.e2 Available from: https:\/\/doi.org\/10.1016\/j.cgh.2017.12.026.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1157_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1053\/j.gastro.2007.05.014","volume":"133","author":"JM Lackner","year":"2007","unstructured":"Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, Blanchard EB. {A figure is presented} How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trial. Gastroenterology. 2007;133(2):433\u201344.","journal-title":"Gastroenterology."},{"issue":"20","key":"1157_CR30","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1002\/sim.1557","volume":"22","author":"AJ Sankoh","year":"2003","unstructured":"Sankoh AJ, D\u2019Agostino RB, Huque MF. Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues. Stat Med. 2003;22(20):3133\u201350.","journal-title":"Stat Med"},{"issue":"2","key":"1157_CR31","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1177\/009286159703100415","volume":"31","author":"A Pong","year":"1997","unstructured":"Pong A, Chow S. Statistical\/practical issues in clinical trials. Drug Inf J. 1997;31(2):1167\u201374 Available from: http:\/\/dij.sagepub.com\/content\/31\/4\/1167.short.","journal-title":"Drug Inf J"},{"issue":"2","key":"1157_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","volume":"11","author":"CY Francis","year":"1997","unstructured":"Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395\u2013402 Available from: http:\/\/doi.wiley.com\/10.1046\/j.1365-2036.1997.142318000.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"1157_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00535-006-1799-9","volume":"41","author":"M ShinozValidationaki","year":"2006","unstructured":"ShinozValidationaki M, Kanazawa M, Sagami Y, Endo Y, Hongo M, Drossman DA, et al. Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index. J Gastroenterol. 2006;41(5):491\u20134.","journal-title":"J Gastroenterol"},{"issue":"2","key":"1157_CR34","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1023\/A:1018831127942","volume":"43","author":"DL Patrick","year":"1998","unstructured":"Patrick DL, Drossman DA, Frederick IO, Dicesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998;43(2):400\u201311.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1157_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1751-0759-1-6","volume":"1","author":"M Kanazawa","year":"2007","unstructured":"Kanazawa M, Drossman DA, Shinozaki M, Sagami Y, Endo Y, Palsson OS, et al. Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J). Biopsychosoc Med. 2007;1(1):6 Available from: http:\/\/bpsmedicine.biomedcentral.com\/articles\/10.1186\/1751-0759-1-6.","journal-title":"Biopsychosoc Med"},{"issue":"7","key":"1157_CR36","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/j.1572-0241.2007.01283.x","volume":"102","author":"D Drossman","year":"2007","unstructured":"Drossman D, Morris CB, Hu Y, Toner BB, Diamant N, Whitehead WE, et al. Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. Am J Gastroenterol. 2007;102(7):1442\u201353.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1157_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF01535722","volume":"33","author":"J Svedlund","year":"1988","unstructured":"Svedlund J, Sjodin I, Dotevall G. GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33(2):129\u201334 Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3123181.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1157_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/A:1008841022998","volume":"7","author":"DA Revicki","year":"1998","unstructured":"Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998;7(1):75\u201383.","journal-title":"Qual Life Res"},{"issue":"7","key":"1157_CR39","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1023\/A:1024159226274","volume":"48","author":"S Gordon","year":"2003","unstructured":"Gordon S, Ameen V, Bagby B, Shahan B, Jhingran P, Carter E. Validation of irritable bowel syndrome global improvement scale: an integrated symptom end point for assessing treatment efficacy. Dig Dis Sci. 2003;48(7):1317\u201323.","journal-title":"Dig Dis Sci"},{"issue":"9","key":"1157_CR40","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"1157_CR41","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder. Arch Intern Med. 2006;166(10):1092 Available from: http:\/\/archinte.jamanetwork.com\/article.aspx?doi=10.1001\/archinte.166.10.1092.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1157_CR42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53\u201372 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10158943.","journal-title":"Health Policy"},{"issue":"4","key":"1157_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1037\/1082-989X.2.4.371","volume":"2","author":"Bengt O. Muth\u00e9n","year":"1997","unstructured":"Muth\u00e9n BO, Curran PJ. General longitudinal modeling of individual differences in experimental designs: a latent variable framework for analysis and power estimation. Psychol Methods. 1997;2(4):371\u2013402.","journal-title":"Psychological Methods"},{"key":"1157_CR44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/pst.267","volume":"7","author":"P Lane","year":"2008","unstructured":"Lane P. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches. Pharm Stat. 2008;7:93\u2013106 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19499510.","journal-title":"Pharm Stat"},{"key":"1157_CR45","unstructured":"ICMJE. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. Citeseer. 2016:1\u201317 Available from: http:\/\/citeseerx.ist.psu.edu\/viewdoc\/download?doi=10.1.1.408.8144&rep=rep1&type=pdf."},{"issue":"1","key":"1157_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0005-7894(98)80016-6","volume":"29","author":"A Vollmer","year":"1998","unstructured":"Vollmer A, Blanchard EB. Controlled comparison of individual versus group cognitive therapy for irritable bowel syndrome. Behav Ther. 1998;29(1):19\u201333.","journal-title":"Behav Ther"},{"issue":"9718","key":"1157_CR47","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S0140-6736(09)62164-4","volume":"375","author":"SE Lamb","year":"2010","unstructured":"Lamb SE, Hansen Z, Lall R, Castelnuovo E, Withers EJ, Nichols V, et al. Group cognitive behavioural treatment for low-back pain in primary care: a randomised controlled trial and cost-effectiveness analysis. Lancet. 2010;375(9718):916\u201323 Available from: https:\/\/doi.org\/10.1016\/S0140-6736(09)62164-4.","journal-title":"Lancet"},{"issue":"21","key":"1157_CR48","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/00006842-199609000-00013","volume":"58","author":"AM van Dulmen","year":"1996","unstructured":"van Dulmen AM, Fennis JFM, Bleijenberg G. Cognitive-behavioral group therapy for irritable bowel syndrome: effects and long-term follow-up. Psychosom Med. 1996;58(21):508\u201314.","journal-title":"Psychosom Med"},{"issue":"1","key":"1157_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1023\/A:1022809914863","volume":"10","author":"GA Tkachuk","year":"2003","unstructured":"Tkachuk GA, Graff LA, Martin GL, Bernstein CN. Randomized controlled trial of cognitive-behavioral group therapy for irritable bowel syndrome in a medical setting. J Clin Psychol Med Settings. 2003;10(1):57\u201369.","journal-title":"J Clin Psychol Med Settings"},{"issue":"4","key":"1157_CR50","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.brat.2006.07.003","volume":"45","author":"EB Blanchard","year":"2007","unstructured":"Blanchard EB, Lackner JM, Sanders K, Krasner S, Keefer L, Payne A, et al. A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome. Behav Res Ther. 2007;45(4):633\u201348.","journal-title":"Behav Res Ther"},{"issue":"1","key":"1157_CR51","first-page":"45","volume":"3","author":"V Renjith","year":"2017","unstructured":"Renjith V. Blinding in randomized controlled trials : what researchers need to know ? Manipal J Nurs Heal Sci. 2017;3(1):45\u201350.","journal-title":"Manipal J Nurs Heal Sci"},{"issue":"5","key":"1157_CR52","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/jama.2017.21903","volume":"319","author":"M Calvert","year":"2018","unstructured":"Calvert M, Kyte D, Mercieca-Bebber R, Slade A, Chan AW, King MT. Guidelines for inclusion of patient-reported outcomes in clinical trial protocols the spirit-pro extension. JAMA - J Am Med Assoc. 2018;319(5):483\u201394.","journal-title":"JAMA - J Am Med Assoc"},{"issue":"1","key":"1157_CR53","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J. A power primer. Psychol Bull. 1992;112(1):155\u20139.","journal-title":"Psychol Bull"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-1157-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-020-1157-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-1157-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:20:21Z","timestamp":1612311621000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-020-1157-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,4]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1157"],"URL":"https:\/\/doi.org\/10.1186\/s12876-020-1157-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,4]]},"assertion":[{"value":"20 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the ethics committee of Kyoto University Graduate School of Medicine (reference number C1357). All participants will provide written informed consent prior to participation.This study protocol is based on protocol version 1.2 by the ethics committee of Kyoto University Graduate School of Medicine (R1019) and National Center of Neurology and Psychiatry.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TAF has received lecture fees from Meiji, Mitsubishi-Tanabe, MSD and Pfizer. He is a diplomate of the Academy of Cognitive Therapy. HS has received lecture fees from Astellas and Sumitomo Dainippon. All of the other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}